6th Annual BHIVA Conference for the Management of HIV/Hepatitis Co-infection in collaboration with BASL and BVHG - Presentations

Download Programme Date: Wednesday 13 November 2013

Venue: Queen Elizabeth II Conference Centre, London

Welcome Addresses

Dr Ranjababu Kulasegaram, Chair, BHIVA Hepatitis Society
Professor Graham Foster, Chair, British Association for the Study of the Liver (BASL)
Dr Ashley Brown, Chair, British Viral Hepatitis Group (BVHG)

Plenary Session 1

When to treat HIV/hepatitis co-infection outside drug trials: treat now or wait?
Professor Graham Foster, Queen Mary, University of London

Advances in hepatitis B
Professor Karine Lacombe, Hospital Saint-Antoine, Paris, France

Plenary Session 2

Insights into the immunopathogenesis of liver disease in HCV/HIV co-infected patients
Professor Paul Klenerman, University of Oxford

Treating NASH in HIV co-infection
Professor Mark Thursz, Imperial College Healthcare NHS Trust, London

What's in the pipeline? (part 1)

Dr Mariem Charafeddine, AbbVie Ltd
Mrs Tokunbo Soyemi, Boehringer Ingelheim Ltd
Mr Jonty Manuja, Janssen

Debate - The motion: Should HIV physicians treat patients infected with hepatitis?

For the motion:
Dr Mark Nelson, Chelsea and Westminster Hospital, London

Against the motion:
Dr Kosh Agarwal, King's College Hospital, London

Plenary Session 3

Hepatocellular carcinomas (HCCs)
Professor Norbert Bräu, James J Peters VA Medical Center, New York, USA

Update on liver transplantation in HIV/hepatitis co-infected patients
Dr James O'Beirne, Royal Free Hospital, London

What's in the pipeline? (part 2)

Dr David Butcher, Bristol-Myers Squibb Ltd
Dr Macky Natha, Gilead Sciences Ltd
Dr Valerie Carr, Janssen Therapeutics EMEA
Dr Nadine Chamay, MSD Ltd

Plenary Session 4

BHIVA guidelines for the management of co-infection with HIV-1 and hepatitis viruses update
Dr Ed Wilkins, North Manchester General Hospital

Difficult HIV/hepatitis co-infection case presentation session

A fly in the face
Dr Olubanke Davies, St Thomas' Hospital, London

Hepatitis B/HIV co-infection in renal disease
Dr Anna Goodman, Royal Free Hospital, London

Expanded Access: a marginal decision
Dr Agata Plonczak, Chelsea and Westminster Hospital, London

Close

Dr Ranjababu Kulasegaram, Chair, BHIVA Hepatitis Society
Dr Ashley Brown, Chair, British Viral Hepatitis Group (BVHG) and on behalf of the British Association for the Study of the Liver (BASL)